A Newcastle Disease Virus Expressing a Stabilized Spike Protein of SARS-CoV-2 Induces Protective Immune Responses

0
118
Investigators developed a COVID-19 vaccine candidate based on Newcastle disease virus that could be manufactured at high yields in embryonated eggs.
[Nature Communications]
Full Article